ConductScience.org, home

Paper40941017

Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge.

Caraviello C and 8 others. Cancers (Basel), 2025. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge. Papers, record 40941017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40941017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
9.57, provisional
iCite
Revised in PubMed
2025-09-16
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Caraviello CCamilahttps://orcid.org/0000-0002-9568-792X
2Nazzaro GGianlucahttps://orcid.org/0000-0001-8534-6497
3Tavoletti GGianlucahttps://orcid.org/0000-0001-8901-318X
4Boggio FFrancescahttps://orcid.org/0000-0003-2313-9585
5Denaro NNerinahttps://orcid.org/0000-0002-8605-4290
6Murgia GGiulia
7Passoni EEmanuela
8Benzecry Mancin VValentina
9Marzano AVAngelo Valeriohttps://orcid.org/0000-0002-8160-4169

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References254

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133845460NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.J Natl Compr Canc Netw2021https://conductscience.org/library/papers/33845460PubMed
232238921Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.Br J Cancer2020https://conductscience.org/library/papers/32238921PubMed
37490362Lentigo maligna and lentigo maligna melanoma.J Am Acad Dermatol1995https://conductscience.org/library/papers/7490362PubMed
436564126Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study.J Immunother Cancer2022https://conductscience.org/library/papers/36564126PubMed
531758078Melanoma pathology reporting and staging.Mod Pathol2020https://conductscience.org/library/papers/31758078PubMed
621102518Efficient in vivo microRNA targeting of liver metastasis.Oncogene2011https://conductscience.org/library/papers/21102518PubMed
717131335The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review.Int J Cancer2007https://conductscience.org/library/papers/17131335PubMed
834986285Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.N Engl J Med2022https://conductscience.org/library/papers/34986285PubMed
932015020Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.Clin Cancer Res2020https://conductscience.org/library/papers/32015020PubMed
1025727210Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.J Cutan Pathol2015https://conductscience.org/library/papers/25727210PubMed
1137544359Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.J Mol Diagn2023https://conductscience.org/library/papers/37544359PubMed
1232745161Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis.JAMA Dermatol2020https://conductscience.org/library/papers/32745161PubMed
1315837860First prospective study of the recognition process of melanoma in dermatological practice.Arch Dermatol2005https://conductscience.org/library/papers/15837860PubMed
1415617990Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.Eur J Cancer2005https://conductscience.org/library/papers/15617990PubMed
1528283772Identification, genetic testing, and management of hereditary melanoma.Cancer Metastasis Rev2017https://conductscience.org/library/papers/28283772PubMed
1639709737European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024.Eur J Cancer2025https://conductscience.org/library/papers/39709737PubMed
1739602056Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review.Curr Oncol Rep2024https://conductscience.org/library/papers/39602056PubMed
1826819111Biomarker value and pitfalls of serum S100B in the follow-up of high-risk melanoma patients.J Dtsch Dermatol Ges2016https://conductscience.org/library/papers/26819111PubMed
1930422243Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.JAMA Oncol2019https://conductscience.org/library/papers/30422243PubMed
2037142291Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial.J Immunother Cancer2023https://conductscience.org/library/papers/37142291PubMed

See all 254 referencesDownload CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
42941874Licochalcone A Inhibits Melanoma Cell Survival by Suppressing HSP75 (TRAP1) and Disrupting Cellular Redox and Energy Homeostasis.Int J Mol Sci2026https://conductscience.org/library/papers/42941874PubMed
42929909Carboxymethylcellulose/Hyaluronic Acid Hybrid Nanoconjugates: Toward Multifunctional Platforms for Melanoma Skin Cancer Theranostics.Gels2026https://conductscience.org/library/papers/42929909PubMed
42903663Towards epigenetically informed and biobank-driven precision immunotherapy in melanoma.Front Immunol2026https://conductscience.org/library/papers/42903663PubMed
42882458
Redox Storm in the Tumor Microenvironment (ΤΜΕ): Multifaceted Redox Injury and Immunometabolic Reprogramming Induced by Immune Checkpoint Blockade in B16F10 Melanoma: An Ultrastructural Study of the Peritumoral Interface.
Cells2026https://conductscience.org/library/papers/42882458PubMed
42795718Melanoma Intelligence: Explainable AI Reveals Histopathologic Aggressiveness as the Dominant Axis of Lymph-Node Metastasis.J Clin Med2026https://conductscience.org/library/papers/42795718PubMed
42756612Molecular reprogramming in cutaneous melanoma: the central role of G9a and EZH2 methyltransferase inhibitors in tumor plasticity, immune evasion, and therapeutic resistance.Front Pharmacol2026https://conductscience.org/library/papers/42756612PubMed
42738249The Role of Transcriptional and Atypical Cyclin-Dependent Protein Kinases in Melanoma.Cancers (Basel)2026https://conductscience.org/library/papers/42738249PubMed
42649762Automated Skin Lesion and Cancer Detection Using Computer Vision: A Comprehensive Review.Bioengineering (Basel)2026https://conductscience.org/library/papers/42649762PubMed
42588706Predictive Biomarkers of Systemic Therapy Response in Cutaneous Melanoma.Cancers (Basel)2026https://conductscience.org/library/papers/42588706PubMed
42512381Unravelling the Intricate Mechanism of Cucurbitacin-Mediated Anti-Cancer Therapy.Cancers (Basel)2026https://conductscience.org/library/papers/42512381PubMed
42509856Interaction of Alkannin with CPEB4 Contributes to Its Antitumor Effects in Melanoma.Biomolecules2026https://conductscience.org/library/papers/42509856PubMed
42500571Epigenetic Modulators and Immunotherapy in Malignant Melanoma.Oncol Res2026https://conductscience.org/library/papers/42500571PubMed
42439659
Reshaping the Battlefield: Reprogramming the Melanoma Tumour Microenvironment (TME) by Anti-CTLA-4, Anti-PD-1, and Anti-PD-L1 Monotherapy and Combination Therapy: A Systematic Review and Meta-Analysis of Preclinical and Clinical Evidence.
Cells2026https://conductscience.org/library/papers/42439659PubMed
42358547Multimodal treatment and long-term survival in a rare case of melanoma with pancreatic and splenic metastases: a case report and literature review.Front Oncol2026https://conductscience.org/library/papers/42358547PubMed
42356529Immunosuppressive Pathways in Cutaneous Melanoma: Functional Integration Between PD-1 and CD73 and Therapeutic Implications.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42356529PubMed
42352510Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma.Cancers (Basel)2026https://conductscience.org/library/papers/42352510PubMed
42318376Skin Cancer in the Rural South: Strengthening Dermatologic Training for Frontline Primary Care.Cureus2026https://conductscience.org/library/papers/42318376PubMed
42282857Sarcoidosis-Like Granulomatous Reaction During Adjuvant Pembrolizumab for High-Risk Resected Melanoma.Case Rep Oncol Med2026https://conductscience.org/library/papers/42282857PubMed
42262336Melanoma in an Unlikely Guise: Diagnostic Challenges of a Solid-cystic Popliteal Mass in Neurofibromatosis Type 1.Ann Afr Med2026https://conductscience.org/library/papers/42262336PubMed
42243532PLD1 and PLD2 promote an immunosuppressive tumor microenvironment via CCL19-dependent macrophage polarization and PD-L1 induction.Exp Mol Med2026https://conductscience.org/library/papers/42243532PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40941017

GET https://conductscience.org/api/papers/v1/40941017/references?page=2